Personal skincare product

Abstract

A personal skincare product that provides cleansing, antiseptic, antibacterial, soothing, moisturizing, protective, and healing benefits to irritated skin and wounds for all ages, particularly for consumers with sensitive and fragile skin like children and the elderly. The personal skincare product comprises a topical antiseptic comprising water, benzalkonium chloride, phenoxyethanol, aloe, liquid coconut, propylene glycol, collagen, polyethylene glycol, sodium benzoate, petrolatum, lanolin, mineral oil, cod liver oil, paraffin, sodium, olive oil, cottonseed oil, vitamin E, and a non-ionic copolymer such as Poloxamer 188 or a combination therefrom.

Claims

1. A foam consisting essentially of: water; benzalkonium chloride; phenoxyethanol; aloe; liquid coconut; propylene glycol; collagen; polyethylene glycol; sodium benzoate; mineral oil; cod liver oil; paraffin; sodium salts; olive oil; cottonseed oil; and vitamin E.

2. The foam of claim 1, wherein the water is present in an amount between 75.0-95.0% by weight, the benzalkonium chloride is present in an amount between 0.12-0.14% by weight, the phenoxyethanol is present in an amount between 0.1-2.5% by weight, the aloe is present in an amount between 0.01-5.0% by weight, the liquid coconut is present in an amount between 0.1-2.5% by weight, the propylene glycol is present in an amount between 1.0-20.0% by weight, the collagen is present in an amount between 0.1-5% by weight, the polyethylene glycol is present in an amount between 0.1-2.5% by weight, and the sodium benzoate is present in an amount between 0.01-0.1% by weight.

3. The foam of claim 1, wherein the foam has a pH between 5.0 and 7.0.

4. The foam of claim 1, wherein the foam has a density between 1.001 g/ml-1.190 g/mL.

Description

DETAILED DESCRIPTION

(1) The present invention relates to a non-aerosol personal skincare product. The various components of the present invention, and the manner in which they interrelate, are described in greater detail hereinafter.

(2) The present invention comprises a number of components, each of which have their own purpose and use. Specifically, the foamed, non-aerosol personal skincare product comprises water, benzalkonium chloride, phenoxyethanol, aloe, liquid coconut, propylene glycol, collagen, polyethylene glycol, sodium benzoate, petrolatum, lanolin, mineral oil, cod liver oil, paraffin, sodium, olive oil, cottonseed oil, vitamin E, and a non-ionic copolymer such as Poloxamer 188 or a combination therefrom. Water is the solvent used for the present invention and is preferred over an alcohol-based solvent because it does not evaporate as quickly and leaves no scent or oily residue. Preferably the water is present in an amount between 75.0-95.0% by weight and more preferably between 92-94% by weight. The next ingredient is benzalkonium chloride which serves the provide the antiseptic qualities of the present invention. Preferably, the benzalkonium chloride is present in an amount between 0.12-0.14% by weight. Phenoxyethanol is used as a preservative in the present invention and is commonly present in many cosmetics and personal care products. Preferably the phenoxyethanol is present in an amount between 0.1-2.5% by weight and more preferably in an amount between 0.15-0.25% by weight.

(3) Aloe is included in the present invention to serve as a moisturizer. Preferably, the aloe is present in an amount between 0.01-5.0% by weight and more preferably between 0.01-1.0% by weight. Liquid coconut is included in the present invention to provide fragrance to the present invention and cover over any smell or scent from the other ingredients. Preferably the liquid coconut is present in an amount between 0.1-2.5% by weight and more preferably between 1.0-2.5% by weight.

(4) Propylene glycol is included in the present invention to serve as another solvent and allows for the dissolution of the hydrophobic ingredients into solution. Preferably the propylene glycol is present in an amount between 1.0-20.0% by weight and more preferably in an amount between 2.0-3.0% by weight. Collagen is included in the present invention to serve as a thickening agent and to create a barrier between the wound and open air because once applied to wound and the solvents evaporate, the thickening agents will remain behind to protect the skin. Preferably collagen is present in an amount between 0.1-5.0% by weight and more preferably between 1.0-3.0% by weight. The present invention also employs polyethylene glycol as another thickening agent which is preferably present in an amount between 0.1-2.5% by weight and more preferably between 2.0-2.5% by weight. Sodium benzoate is also present in the invention as a preservative. Preferably the sodium benzoate is present between 0.01-0.1% by weight and more preferably between 0.05-0.1% by weight.

(5) The present invention is stored as a liquid and can be kept at room temperature for long periods of time. Delivery of the present invention to a user's wound or other skin issue is best done as a foam although the invention can be applied in liquid form as well and still achieve a similar result.

(6) The present invention may also alternatively include mineral oil in an amount between 0.0-80.0% by weight to be used as a thickening agent, cod liver oil in an amount between 0.0 10.0% by weight also as a thickening agent, paraffin in an amount between 0.0-10.0% by weight as a thickening agent, sodium salts in an amount between 0.0-10.0% by weight as a preservative, olive oil in an amount between 0.0-10.0% by weight as a moisturizer, cottonseed oil in an amount between 0.0-10.0% by weight as a moisturizer, Vitamin E in an amount between 0.0 and 2.0% by weight as a moisturizer, and non-ionic copolymer such as Poloxamer 188 in an amount between 0.0-10.0% by weight as another type of thickening agent. The present invention may also include at least one antibiotic such as bacitracin zinc, neomycin sulfate, and polymyxin B. To the extent they are included, it is preferred that anywhere from 0-440 units per gram of bacitracin zinc are included, 0-3.5 milligrams of neomycin sulfate are included, and 0-5000 units per gram of polymyxin B are included. The present invention preferably has a density between 1.001-1.190 g/mL and a pH range between 5.0 and 7.0. The present disclosure includes that contained in the appended claims, as well as that of the foregoing description.

(7) Although this invention has been described in its preferred form with a certain degree of particularity, it is understood that the present disclosure of the preferred form has been made only by way of example and that numerous changes in the details of construction and the combination and arrangement of parts may be resorted to without departing from the spirit and scope of the invention.